On December 15, 2021, Innolcon Medical Technology (Hefei) Co., Ltd. was officially established, and on July 12, 2022, Innolcon Hefei successfully completed pilot production of the first batch of ultrasonic scalpels. The leap from establishment to production was achieved in just 7 months. This also marks the formal formation of Innolcon's "one body, two wings" R&D and production pattern, which is of great strategic significance to optimize and improve the company’s overall strategic layout.

       Innolcon, with two manufacturing centers in Suzhou and Hefei (“two wings”) and  joint R&D in both Suzhou and California, USA (“one body”), will set up an overall production layout of ultrasonic surgical system, ultrasonic aspirator system, electrosurgical system, ultrasonic high frequency surgical system, phaco-emulsification surgical system and laparoscopic minimally invasive surgical robots, building a comprehensive platform of surgery, ophthalmology and orthopedics with energy surgical products as the core.

       The official operation of Innolcon's Hefei manufacturing base offers Innolcon stronger manufacturing and production capacity, and provides solid support for further expansion of domestic and overseas markets. With strenuous efforts, Innolcon’s business has expande to more than 60 countries and regions worldwide.

       Supported by national policies and all sectors of society, Innolcon Hefei manufacturing base will sweep ahead full sail and look forward to a brilliant future.